Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Four Wall Street firms have downgraded Weave Communications in the past week. The cluster of analyst cuts is striking — and it tells a specific story about how professionals read the Francisco Partners deal.
Raymond James, B. Riley Securities, Loop Capital, and Piper Sandler all downgraded WEAV between August 18 and August 24. Three of the four also cut price targets to $7.40 — almost exactly where the stock trades now at $7.29.
That convergence on $7.40 is the key signal. It suggests analysts are pricing the stock to the acquisition value, not to any standalone upside. Raymond James moved from Outperform to Market Perform with no new price target at all. B. Riley cut from Buy to Neutral, trimming its target from $8.25 to $7.40. Loop Capital and Piper Sandler followed the same pattern.
The message is uniform: the equity upside is now capped at deal close.
Options positioning has shifted sharply in the same direction. The put/call ratio hit 1.11 on August 19 — the highest in 52 weeks. It remains elevated at 0.97 as of August 21, sitting 2.19 standard deviations above the 20-day mean of 0.25.
Before the Francisco Partners deal was announced on August 18, the PCR was running at 0.10–0.13. That's a near-tenfold increase in put demand in under a week.
Deal arb traders routinely buy puts to hedge deal-break risk. The PCR spike reflects that positioning, not a directional bearish view on the business.
Cost to borrow jumped to 3.25% on August 21 — up 439% week-on-week from 0.47%. A week ago, the previous ORTEX note flagged CTB as cheap and the lending market as relaxed. That has changed.
Availability has tightened too. It dropped to 658% from over 1,500% just two weeks ago — still in the normal range, but falling sharply. Short interest itself is 7.1% of the free float, up 10% week-on-week, as SI continues to build despite the deal announcement.
The CTB spike is consistent with arbitrageurs establishing or maintaining short hedges on the deal premium — borrowing stock to lock in spread trades rather than outright bear positions.
Three separate signals — analyst downgrades, put accumulation, and rising borrow costs — are pointing in the same direction. All three reflect the same underlying trade: the Francisco Partners acquisition converts WEAV from a growth bet into a spread trade.
The $7.40 analyst consensus target sits 1.5% above the current price. Shorts face limited downside from here if the deal closes, but meaningful pain if it falls apart.
What to watch: deal closure confirmation and any movement in the cost to borrow. A sustained CTB move above 5% would signal borrow is tightening materially — and would tell a different story about positioning.
See the live data behind this article on ORTEX.
Open WEAV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
